LinkedIn
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
LinkedIn
Oct 20, 2023, 20:12 |
Insight
Vanina Laurent-Ledru: 4 key take-aways from the session on implementing One Health at the World Health Summit in Berlin
Vanina Laurent-Ledru, Director General at Foundation S- The Sanofi Collective, shared a post on LinkedIn:…
Oct 19, 2023, 17:28 |
Blog
Manush Avagyan: I'm now diving into a year of skill refinement as a physician, scientist, and leader at Harvard Medical School (HMS)
Manush Avagyan, Associate Medical Director at Agenus, recently posted on her LinkedIn: "Exciting News: Harvard…
Oct 18, 2023, 18:00 |
Drugs
Vivek Subbiah: My perspectives of tumor agnostic drug development
Vivek Subbiah recently shared on LinkedIn: "So honored to present the “Future of Tissue-Agnostic Precision…
Sep 23, 2023, 19:58 |
Blog
Humaid Al-Shamsi: The opening ceremony of the largest and most prominent oncology conference in the UAE will be held under the esteemed patronage and presence of H.E. Sheikh Nahayan Mabarak Al Nahayan.
Sep 23, 2023, 19:53 |
Opinion
Olubukola Ayodele: Don’t be part of the pinkwashing, rather, choose to be part of the change many women/men so desperately need.
Olubukola Ayodele, Consultant Medical Oncologist at University Hospitals of Leicester NHS Trust, shared on LinkedIn:…
Sep 22, 2023, 11:56 |
Positive
Dean Crowe: Grateful for these two!
Quoting Dean Crowe, Founder and CEO of Rally Foundation for Childhood Cancer Research, on LinkedIn:…
Sep 22, 2023, 11:50 |
Blog
The President of Union for International Cancer Control lauds the progress made towards quality cancer control.- Union for International Cancer Control
Quoting the Union for International Cancer Control (UICC) on LinkedIn: ""The great hope of my…
Sep 21, 2023, 18:12 |
Insight
Fiona Hamilton Marshall: These are hopeful findings for patients with relapsed/refractory diffuse large B-cell lymphomawho may not have a durable response to existing therapies.
Sep 21, 2023, 17:56 |
Blog
Karima Oualla: We invite you to fill out this survey that takes no more than 3 minutes to complete.
Quoting Karima Oualla, Professor of Medical Oncology at Hassan II University Hospital, on LinkedIn: "Dear…
Sep 21, 2023, 17:50 |
Insight
TIGIT bispecific program is advancing in clinical trials for non-small cell lung and gastric cancers. - Agenus
Agenus shared on LinkedIn: “Our partner, Bristol Myers Squibb, unveiled exciting updates at their recent…
1
2
3
4
5
All:
122
Posts:
11 - 20
OncoInfluencers: Dialogue with Rob Pieters, hosted by Shushan Hovsepyan
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Facebook
RSS Feed
Twitter
Linkedin
Youtube